BioPharma Today

Coming In Monday's "The Pink Sheet" DAILY - News From The BIO-Windhover Pharmaceutical Strategic Outlook Conference

Big pharmas and biotechs alike need to consider the impact of reimbursement on a product's market opportunity when structuring deals, given the growing influence of payers, but industry execs grappled with how to do this at the BIO-Windhover Pharmaceutical Strategic Outlook conference in New York City on Feb. 24.

Daiichi Sankyo, Bayer, Japan's Dispensing Rule, New Zealand Drug Prices - Latest From PharmAsia News

Daiichi Sankyo Goes After Generics In Japan, Forms New Company With Ranbaxy

02/26/10 11:16 GMT

Latest News from "The Pink Sheet" DAILY - GSK Doubles Up With Regulus

Watson Is Bullish On Launching Enhanced Ferrlecit Generic Soon

Watson's own citizen petitions blocking generics won't be an obstacle, company says.   read more

Editors' Picks from the World Press

Pipeline/RD News

• Transplant drug shows promise in treating Alzheimer's disease
• Sunesis will conduct late-stage trial of leukemia drug this year
• Avastin helps stall ovarian cancer progression, study finds

Business Finance

• Biolex lands $10 million in additional financing
• GSK will develop hepatitis C drugs with Regulus

Government Legal News

• FDA needs 5 extra days to evaluate diabetes drug exenatide
• Arena's weight-loss pill is accepted for FDA review
• FDA pushes back review deadline for Theratechnologies' tesamorelin
• FDA reviewers voice concern about side effects of belatacept

Simcere's Generic Relenza, Astellas-Basilea Phase III Deal - Latest From PharmAsia News

China State FDA Grants Simcere Record Fast-track Approval To Market Generic Relenza

02/25/10 10:57 GMT

Coming in Friday's "The Pink Sheet" DAILY - President Obama Meets with Congressional Leaders to push forward health care reform bill

President Obama meets with administration officials and Democrat and Republican leaders of the House and Senate during the anticiapted bipartisan health care reform summit, where both sides will try and find some common ground to move legislation forward.

Latest News From "The Pink Sheet" DAILY - Pfizer's Prevnar 13 Vaccine Clears FDA

ACIP's Support Of FDA-Approved Prevnar 13 Creates Opportunity For Larger Market

Editors' Picks from the World Press

Pipeline/RD News

• Relapse in melanoma patients pushes doctor to call for combo trials

Coming in Thursday's "The Pink Sheet" DAILY - Anthera Pharmaceutials Postpones IPO

Anthera Pharmaceuticals has postponed an initial public offering through which it hoped to raise $64 million by selling 4.6 million shares of stock in the $13-$15 price range.

Pfizer, Lilly, Merck And Dr. Reddy's - Latest From PharmAsia News

Pfizer, Lilly And Merck Strike Up Cancer Research Partnership In Asia

02/24/10 5:28 GMT